Ketamine in neuropsychiatric disorders: an update

JN Johnston, B Kadriu, C Kraus, ID Henter… - …, 2024 - nature.com
The discovery of ketamine as a rapid-acting antidepressant led to a new era in the
development of neuropsychiatric therapeutics, one characterized by an antidepressant …

[HTML][HTML] The role of ketamine in the treatment of bipolar depression: a scoping review

MY Jawad, S Qasim, M Ni, Z Guo, JD Di Vincenzo… - Brain Sciences, 2023 - mdpi.com
Bipolar depression remains a clinical challenge with a quarter of patients failing to respond
to initial conventional treatments. Although ketamine has been extensively studied in …

Working with weirdness: A response to “moving past mysticism in psychedelic science”

JJ Breeksema, M Van Elk - ACS pharmacology & translational …, 2021 - ACS Publications
In response to a recent call to rid psychedelic science of the concept of mystical experience,
we argue that acknowledging the varieties and weirdness of psychedelic experiences …

A systematic review and meta-analysis of the efficacy of ketamine and esketamine on suicidal ideation in treatment-resistant depression

YT Wang, XL Wang, L Lei, ZY Guo, FF Kan… - European journal of …, 2024 - Springer
Purpose To systematically assess the evidence of efficacy and safety of the use of ketamine
and esketamine for patients with treatment-resistant depression (TRD) with suicidal ideation …

Ketamine for Treatment‐Resistant bipolar depression—A reality check!

B Singh - Bipolar Disorders, 2023 - search.ebscohost.com
Ketamine is a novel drug used for treatment-resistant depression. KETAMINE RESPONSE
AND BIPOLAR DISORDER SUBTYPE This study raises an important question-does …

Ketamine for bipolar depression: an updated systematic review

F Fancy, S Haikazian, DE Johnson… - Therapeutic …, 2023 - journals.sagepub.com
Background: The therapeutic potential of subanesthetic doses of ketamine appears
promising in unipolar depression; however, its effectiveness in treating bipolar depression …

[HTML][HTML] An Update on the Efficacy of Single and Serial Intravenous Ketamine Infusions and Esketamine for Bipolar Depression: A Systematic Review and Meta …

NA Nunez, B Joseph, R Kumar, I Douka, A Miola… - Brain Sciences, 2023 - mdpi.com
Ketamine has shown rapid antidepressant and anti-suicidal effects in treatment-resistant
depression (TRD) with single and serial intravenous (IV) infusions, but the effectiveness for …

Targeting inflammasome complexes as a novel therapeutic strategy for mood disorders

AS de Miranda, EC de Brito Toscano… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Inflammasome complexes, especially the NLRP3, have gained great attention
as a potential therapeutic target in mood disorders. NLRP3 triggers a caspase 1-dependent …

[HTML][HTML] Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management

A Wilkowska, WJ Cubała - Frontiers in Psychiatry, 2023 - frontiersin.org
Bipolar depression constitutes a major problem in psychiatry. It correlates with high
suicidality, treatment resistance, chronicity, and poor quality of life. Registered treatment for …

[HTML][HTML] Fabrication of a Controlled-Release Core-Shell Floating Tablet of Ketamine Hydrochloride Using a 3D Printing Technique for Management of Refractory …

T Karami, E Ghobadi, M Akrami, I Haririan - Polymers, 2024 - mdpi.com
In this study, a novel floating, controlled-release and core-shell oral tablet of ketamine
hydrochloride (HCl) was produced using a dual extrusion by 3D printing method. A mixture …